Masakatsu Kotsuma
Daiichi Sankyo (Germany)(DE)Daiichi-Sankyo (Japan)(JP)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Radiopharmaceutical Chemistry and Applications, Cancer Immunotherapy and Biomarkers, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Regression of Inflammation in Atherosclerosis by the LXR Agonist R211945(2012)75 cited
- → Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a(2018)59 cited
- → Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer(2015)37 cited
- → Pharmacokinetics, distribution, and disposition of esaxerenone, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist, in rats and monkeys(2016)33 cited
- → Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a(2016)30 cited
- → Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective(2021)28 cited
- → Predictive Modeling of Drug Response in Non-Hodgkin’s Lymphoma(2015)25 cited
- → A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers(2022)24 cited
- → Molecular Simulation of Receptor Occupancy and Tumor Penetration of an Antibody and Smaller Scaffolds: Application to Molecular Imaging(2017)24 cited
- → In Vitro and In Vivo Evaluation of 89Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy(2016)20 cited